These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 3867980)
21. NIH ethics office clamps down on Duke...as basic scientists feel the pinch in LA. Wadman M Nature; 1999 May; 399(6733):190. PubMed ID: 10353232 [No Abstract] [Full Text] [Related]
22. The NIH trials of growth hormone for short stature. Tauer CA IRB; 1994 May; 16(3):1-9. PubMed ID: 11659923 [No Abstract] [Full Text] [Related]
23. Federal agency keeps review committee after public comments support continuation. Maloney DM Hum Res Rep; 1997 Jan; 12(1):1-2. PubMed ID: 11654603 [No Abstract] [Full Text] [Related]
24. Beyond localism: a proposal for a National Research Review Board. Levine C; Caplan AL IRB; 1986; 8(2):7-9. PubMed ID: 11649751 [No Abstract] [Full Text] [Related]
26. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials. Weijer C IRB; 1998; 20(2-3):1-5. PubMed ID: 11656912 [No Abstract] [Full Text] [Related]
27. The concept of the IRB and bureaucratic reality: an exchange of letters. van Eys J; Levine RJ IRB; 1984; 6(4):8-10. PubMed ID: 11649563 [No Abstract] [Full Text] [Related]
28. Evolution of the NIH guidelines. Milewski EA Recomb DNA Tech Bull; 1981 Dec; 4(4):160-5. PubMed ID: 7029672 [No Abstract] [Full Text] [Related]
29. Cracks in the RAC. Gershon D Nature; 1991 Oct; 353(6345):591. PubMed ID: 1922377 [No Abstract] [Full Text] [Related]
30. Discussions on human gene therapy. Milewski EA Recomb DNA Tech Bull; 1986 Jun; 9(2):88-130. PubMed ID: 3532218 [No Abstract] [Full Text] [Related]
31. Government regulation of human gene therapy. Gage JL Jurimetrics; 1987; 27(2):200-18. PubMed ID: 11651978 [No Abstract] [Full Text] [Related]
32. Ethical issues in clinical neurological research. Shore D; Berg K; Mullican C J Calif Alliance Ment Ill; 1994; 5(1):61-2. PubMed ID: 11653329 [No Abstract] [Full Text] [Related]
33. US bioethics panel poised to judge local review boards. Macilwain C Nature; 1996 Oct; 383(6600):466. PubMed ID: 8849708 [No Abstract] [Full Text] [Related]
34. The revised "Points to Consider" document. Hum Gene Ther; 1990; 1(1):93-103. PubMed ID: 2081190 [No Abstract] [Full Text] [Related]
35. Fears mount for gene scrutiny as watchdog faces axe. Kiernan V New Sci; 1996 Jun; 150(2033):10. PubMed ID: 11656540 [No Abstract] [Full Text] [Related]
36. Research compliance changes will affect rules on protection of human subjects. Maloney DM Hum Res Rep; 1999 May; 14(5):1-2. PubMed ID: 11657776 [No Abstract] [Full Text] [Related]
37. Toward a more comprehensive approach to protecting human subjects: the interface of data safety monitoring boards and institutional review boards in randomized clinical trials. Gordon VM; Sugarman J; Kass N IRB; 1998; 20(1):1-5. PubMed ID: 11655324 [No Abstract] [Full Text] [Related]
38. Exempt research: procedures in the intramural research program of the National Institutes of Health. Wichman A; Mills D; Sandler AL IRB; 1996; 18(2):3-5. PubMed ID: 11654755 [No Abstract] [Full Text] [Related]
39. Federal report says protection of human subjects is threatened by numerous factors. Maloney DM Hum Res Rep; 1996 May; 11(5):1-3. PubMed ID: 11654438 [No Abstract] [Full Text] [Related]
40. The regulation of human experimentation in the United States--a personal odyssey. Katz J IRB; 1987; 9(1):1-6. PubMed ID: 11649890 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]